Results 131 to 140 of about 16,262,576 (403)

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

MONEY AS A GLOBAL PUBLIC GOOD [PDF]

open access: yes
The main objective of this paper is to discuss a complex and yet not taken in consideration global public good: money. Money is a social convention created and accepted by people in order to facilitate economic transactions, being a symbol, without an ...
Popescu Alexandra-Codruta
core  

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Evolution of toxins as a public good in phytoplankton. [PDF]

open access: yesProc Biol Sci, 2022
Ehrlich E, Thygesen UH, Kiørboe T.
europepmc   +1 more source

Public Good Menus and Feature Complementarity [PDF]

open access: yes
The distance metric on the location space for multidimensional public good varieties represents complementarity between the goods features. "Euclidean" feature complementarity has atypical strong properties that lead to a failure of intuition about the ...
Christian Roessler
core  

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Competition among public good providers for donor rewards. [PDF]

open access: yesExp Econ, 2022
Struwe N, Blanco E, Walker JM.
europepmc   +1 more source

Public-good valuation and intrafamily allocation [PDF]

open access: yes
I derive the value of marginal changes in a public good for two-person households, measured alternatively by household member i’s willingness to pay (WTP) for the good on behalf of the household, WTPi(H), or by the sum of individual WTP values across ...
Strand, Jon
core  

Razmerje med evidentiranjem in pravnimi režimi na področju voda ; The relation between recording and legal arrangements in water management [PDF]

open access: yesGeodetski Vestnik, 2012
V članku so podane opredelitve načina evidentiranja voda glede na različne pravne podlage. Podana so določila Zakona o vodah, o evidentiranju vodnih zemljišč v javnih nepremičninskih evidencah in pravila, ki se glede evidentiranja voda uporabljajo v ...
Nuša Marolt, Marijana Vugrin
doaj  

Home - About - Disclaimer - Privacy